Product image of Niquitin Mini (Nicotine) supplied by GNH India

Niquitin Mini

Active Ingredient:
Nicotine
Origin:
EU

Niquitin Mini (Nicotine)

Nicotine, the active ingredient in Niquitin Mini, is a nicotinic receptor agonist presented as an oromucosal product for use on the oral mucosa. It is employed to aid smoking cessation in adult individuals who are trying to quit tobacco and to lessen nicotine withdrawal symptoms.

GNH India supplies Niquitin Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, with established distribution channels across the EU, Middle East and Asia and adhering to stringent quality standards.

Manufacturer / TM Owner

Perrigo Poland Sp. Z.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nicotine, a nicotinic receptor agonist, is used in smoking cessation to mitigate nicotine withdrawal and support quitting efforts.

  • Smoking cessation: helps reduce cravings and withdrawal symptoms in adults attempting to quit tobacco.
  • Tobacco dependence: provides a controlled nicotine source to facilitate gradual reduction of nicotine intake.
  • Relapse prevention: assists former smokers in maintaining abstinence by alleviating occasional urges.

How It Works

  • Nicotine binds to nicotinic acetylcholine receptors located on the oral mucosal epithelium, activating them and mimicking the pharmacologic effects of inhaled tobacco nicotine. This stimulation releases dopamine and other neurotransmitters in the brain’s reward pathways, thereby reducing the intensity of withdrawal symptoms and cravings associated with nicotine abstinence. The localized delivery avoids systemic spikes, providing a steadier plasma concentration that supports the transition away from cigarettes.

Side Effects

Nicotine administered via Niquitin Mini may cause a range of oral and systemic reactions.

Common Side Effects

  • Mouth irritation: mild soreness or tingling in the oral cavity.
  • Nausea: transient feeling of queasiness.
  • Headache: mild to moderate headache.
  • Dizziness: brief episodes of light‑headedness.
  • Increased salivation: temporary excess saliva production.

Serious or Rare Side Effects

  • Allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Cardiovascular events: palpitations or chest pain.
  • Severe nausea/vomiting: persistent and intense gastrointestinal upset.
  • Hypotension: unusually low blood pressure.
  • Throat ulceration: persistent sore throat or ulcer formation.

Precautions & Warnings

When using Niquitin Mini, consider the following precautions to ensure safe and effective use.

  • Age restriction: not recommended for individuals under 18 years of age.
  • Cardiovascular disease: use with caution in patients with heart conditions.
  • Diabetes: monitor blood glucose as nicotine may affect glycemic control.
  • Pregnancy and lactation: safety not established; consult a healthcare professional before use.
  • Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously to prevent excess dosing.
  • Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Nicotine can interact with other medicines; awareness of major and moderate interactions helps avoid adverse outcomes.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis.
  • Beta‑blockers: nicotine can reduce their effectiveness in controlling heart rate.

Moderate Interactions (Monitor Closely)

  • Antidepressants (SSRIs, SNRIs): may enhance side‑effects such as insomnia or agitation.
  • Antihypertensive agents: nicotine may counteract blood pressure‑lowering effects.
  • Caffeine: nicotine can increase stimulant effects, leading to jitteriness.

Frequently Asked Questions

Niquitin Mini is an oromucosal nicotine product intended to help adult smokers reduce cravings and manage withdrawal symptoms during a quit attempt. It is part of nicotine replacement therapy strategies aimed at supporting smoking cessation.

The nicotine in Niquitin Mini binds to nicotinic acetylcholine receptors on the oral mucosa, stimulating the same neural pathways activated by cigarette smoke. This activation releases dopamine and other neurotransmitters, which eases withdrawal and diminishes the urge to smoke.

The appropriate dose of Niquitin Mini is determined by a qualified healthcare professional based on the individual’s smoking history, level of dependence, and overall health. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

Safety of nicotine replacement products, including Niquitin Mini, has not been established for pregnant or lactating women. Healthcare providers should be consulted to weigh potential risks and benefits before use in these populations.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Niquitin Mini. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Niquitin Mini delivers nicotine directly to the oral mucosa, offering rapid absorption similar to lozenges or gum, but without the need for chewing. Compared with patches, it provides quicker symptom relief, while the oromucosal route may be preferred by users who dislike oral irritation from gum.

Store Niquitin Mini below 25 °C in its original packaging, protecting it from moisture, heat and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures that could affect its stability.

The product is placed in the mouth and allowed to dissolve slowly against the oral mucosa, following the prescriber’s instructions. It should not be swallowed whole; instead, allow it to release nicotine gradually for optimal absorption.

Serious risks include allergic reactions such as rash, swelling or difficulty breathing, and cardiovascular events like palpitations or chest pain. Users should seek immediate medical attention if any of these symptoms occur.

Individuals under 18 years of age, patients with uncontrolled cardiovascular disease, and anyone who is pregnant or breastfeeding without medical guidance should avoid using Niquitin Mini. Additionally, people already using other nicotine replacement therapies should not combine them without professional advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nicotine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT